Title:
OPHTHALMIC FILM FORMULATION
Document Type and Number:
WIPO Patent Application WO/2017/033967
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide: an ophthalmic film formulation whereby it becomes possible to migrate a dye, a test drug or a local anesthetic drug onto the surface of an eye rapidly through a tear fluid present on the surface of the eye without the need of putting drops of physiological saline on the surface of the eye; and a therapeutic agent which can be used in combination with the ophthalmic film formulation. The ophthalmic film formulation 10 according to the present invention comprises a non-water-soluble support 20, any one of a dye, a test drug and a local anesthetic drug, and a water-soluble film 30 containing polyvinylpyrrolidone, wherein a part of the surface of the non-water-soluble support 20 is in contact with the water-soluble film 30.
Inventors:
TASAKA FUMITAKA (JP)
INAGAKI KOJI (JP)
UMEZAKI SHINYA (JP)
DOTA ATSUYOSHI (JP)
ICHIKAWA SANAE (JP)
NISHIMURA MISAO (JP)
ASANO HARUKA (JP)
INAGAKI KOJI (JP)
UMEZAKI SHINYA (JP)
DOTA ATSUYOSHI (JP)
ICHIKAWA SANAE (JP)
NISHIMURA MISAO (JP)
ASANO HARUKA (JP)
Application Number:
PCT/JP2016/074654
Publication Date:
March 02, 2017
Filing Date:
August 24, 2016
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
TSUKIOKA FILM PHARMA CO LTD (JP)
TSUKIOKA FILM PHARMA CO LTD (JP)
International Classes:
A61K47/32; A61K9/70; A61K31/245; A61K47/22; A61K49/00; A61P27/02
Foreign References:
JP2012045379A | 2012-03-08 | |||
JPH0411229A | 1992-01-16 | |||
JP2014166350A | 2014-09-11 | |||
JP2006116071A | 2006-05-11 |
Attorney, Agent or Firm:
SHOBAYASHI, Masayuki et al. (JP)
Download PDF: